Posts tagged ‘VeriStrat’
Lung cancer specialist Karen Reckamp, M.D., is tired of seeing what the disease does to her patients. She’s deep into researching targeted therapies for lung cancer so she can offer up better treatment options.
The disease has been the leading cause of cancer deaths for a long time, but researchers like her are making some progress. Scientists recently announced, for example, that more than half of cases of a type of lung cancer have genetic mutations that might make them vulnerable to existing drugs or drugs in development.
They still need to figure out if hitting the mutations will stunt lung cancer, but the door of opportunity is open much wider than it has been before.
Along these lines, Reckamp recently presented a study at lung cancer conference in Chicago on a possible test to help choose the most effective therapy for patients with the most common form of lung cancer.
The test might predict which non-small-cell lung cancer patients would respond better to a combination treatment, rather than one drug alone.